Journal
JOURNAL OF PHARMACOLOGICAL SCIENCES
Volume 94, Issue 3, Pages 221-232Publisher
JAPANESE PHARMACOLOGICAL SOC
DOI: 10.1254/jphs.94.221
Keywords
hypoxia-inducible factor (HIF); HIF-related disease; HIF competitor; HIF inhibitor
Categories
Ask authors/readers for more resources
Hypoxia-inducible factor I (HIF-1) Is a transcription factor that functions as a master regulator of oxygen homeostasis. HIF-1 regulates the expressions of the proteins that increase oxygen delivery, which enables cells to survive in oxygen-deficient conditions. Based on information as to which types of genes are controlled by HIF-1, it appears that HIF-1 provides pathological tissues with survival in hypoxic regions or angiogenic activity. Therefore, HIF-1 inhibitors could be useful as therapeutic agents for various diseases associated with the over-activation of HIF-1, such as cancers, cardiovascular remodeling, preeclamsia, and other angiogenesis-related diseases. In this review, we summarize the oxygen-dependent and -independent regulation of HIF-1 and introduce prospective HIF-1 inhibitors that might be useful in the treatment of HIF-1-related diseases.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available